Influence of haemodialysis on high-sensitivity C-reactive protein, lipoprotein(a), apolipoproteins A and B

Clinical Biochemistry

Volumn 40, Issue 16-17, 2007, Pages 1336-1338

  Lippi, Giuseppe ^a   Tessitore, Nicola ^a   Luca Salvagno, Gian ^a   Bedogna, Valeria ^a   Bassi, Antonella ^a   Montagnana, Martina ^a   Lupo, Antonio ^a   Cesare Guidi, Gian ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Apolipoprotein; Chronic renal failure; Haemodialysis; High sensitivity C reactive protein; Lipoprotein(a)

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; C REACTIVE PROTEIN; LIPOPROTEIN A;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; LIPID MEMBRANE; LIPID METABOLISM; MALE; MEMBRANE TRANSPORT; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

AGED; AGED, 80 AND OVER; APOLIPOPROTEINS; APOLIPOPROTEINS A; APOLIPOPROTEINS B; C-REACTIVE PROTEIN; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 35248893442     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.07.007     Document Type: Article

References (10)

1. Kaysen G.A. Dyslipidemia in chronic kidney disease: causes and consequences. Kidney Int. 70 (2006) S55-S58
2. Lippi G., and Guidi G. Biochemical risk factors and patient's outcome: the case of lipoprotein(a). Clin. Chim. Acta 280 (1999) 59-71
3. Longenecker J.C., Klag M.J., Marcovina S.M., et al. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients. J. Am. Soc. Nephrol. 16 (2005) 1794-1802
4. Astor B.C., Eustace J.A., Klag M.J., et al. CHOICE Study. Race-specific association of lipoprotein(a) with vascular access interventions in hemodialysis patients: the CHOICE Study. Kidney Int. 61 (2002) 1115-1123
5. Diaz-Peromingo J.A., Carbajal D.G., and Alban-Salgado A. Lipoprotein(a) in patients on hemodialysis. Acta Med. Austriaca 31 (2004) 73-75
6. Schumacher M., Kebler A., Bahlemann G., and Wood W.G. Acute changes in concentrations of apolipoproteins A-I, B, C-II and lipoprotein(a) in serum covering the period from directly before to 48 hours after chronic haemodialysis. Eur. J. Clin. Chem. Clin. Biochem. 32 (1994) 123-125
7. Tzanatos H.A., Agroyannis B., Chondros C., et al. Cytokine release and serum lipoprotein(a) alterations during hemodialysis. Artif. Organs 24 (2000) 329-333
8. Ramharack R., Barkalow D., and Spahr M.A. Dominant negative effect of TGF-beta1 and TNF-alpha on basal and IL-6-induced lipoprotein(a) and apolipoprotein(a) mRNA expression in primary monkey hepatocyte cultures. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 984-990
9. Diop M.E., Viron B., Bailleul S., et al. Lp(a) is increased in hemodialysis patients according to the type of dialysis membrane: a 2-year follow-up study. Clin. Nephrol. 54 (2000) 210-217
10. House A.A., Wells G.A., Donnelly J.G., Nadler S.P., and Hebert P.C. Randomized trial of high-flux vs low-flux haemodialysis: effects on homocysteine and lipids. Nephrol. Dial. Transplant. 15 (2000) 1029-1034